Casdin Partners Master Fund, L.P. bought LAB
March 5, 2024 · Form 4 insider transaction
Casdin Partners Master Fund, L.P. bought 1,403 shares of Standard BioTools Inc. at $2.62 per share, a transaction worth $3.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,403
Price
$2.62
Total value
$3.7K
Role—
CompanyStandard BioTools Inc. (LAB)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 5, 2024
Filing dateMarch 6, 2024
Shares owned after11,497,928
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.